Skip to main content
Home
 
 
 
MENU
Home
Janssen’s COVID-19 Vaccine Status >

Janssen Global Main Menu

  • Our Company
    • About Us
    • Contact Us
    • Grants & Giving
    • News Center
    • Our Leaders
    • Patient Safety information
    • Products
    • Sustainability
    • Transparency
    • VISIT JANSSEN IN YOUR COUNTRY
  • Our Focus
    • Therapeutic Areas
    • Cardiovascular, Metabolism and Retina
    • Immunology
    • Infectious Diseases & Vaccines
    • Neuroscience
    • Oncology
    • Pulmonary Hypertension
    • Patient Engagement
  • Our Science
    • Our Response to COVID-19
    • Clinical Trials
    • Compassionate Use & Pre-Approval Access
    • R&D Data Science
    • Janssen Global Trial Finder
    • World Without Disease Accelerator
    • Janssen Clinical Innovation
    • Precision Medicine & Janssen Diagnostics

Our Stories List

Making a Splash for Disease Awareness
Global_Trial_Finder
Making a Splash for Disease Awareness
Looking Under the Hood for Green Chemistry Solutions
Global_Trial_Finder
Looking Under the Hood for Green Chemistry Solutions
  • Return to home

Global Trial Finder

  • text size

My Saved Trials

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Last Updated   May 14, 2025

Want to learn how to participate in this trial?

NANORAY-312

OVERVIEW

  • Sexes Eligible for Study
    all
  • Age
    60+ years
  • Phase
    phase 3
  • Sites
    159 Sites
  • Status
    Recruiting

SUMMARY

Participants will undergo a screening assessment over a period of less than or equal to (<=) 28 days to determine eligibility. Eligible participants will be treated by the Investigator's choice of RT alone or RT in combination with cetuximab. Following the Investigator's choice, participants will be randomized in a 1:1 ratio: * Arm A: JNJ-90301900 (NBTXR3), as an intratumoral/intranodal injection, activated by investigator's choice of RT alone or RT in combination with cetuximab * Arm B: Investigator's choice of RT alone or RT in combination with cetuximab All participants (Arm A and Arm B) will receive 70 Gy in 35 fractions over a 7 week period. An EOT visit will be performed 4 weeks after the completion of RT. Follow-up visits will start at 12 weeks post-RT completion, and will continue every 12 weeks for 2 years, and then every 24 weeks thereafter until death; the participant is determined to be lost to follow up; withdrawal of consent; or the end of the study, whichever occurs first. Participants who have received further anti-cancer therapy for the study disease and/or have had disease progression/recurrence will be followed only for survival information

CONDITIONS

  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Aged

ELIGIBILITY


Inclusion Criteria:

* Age greater than or equal to (>=) 60 years old
* Squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or supraglottic larynx and a candidate for definitive radiation therapy with or without cetuximab
* Clinical stage T3-4 NX or T2 N2-3 disease according to the 8th edition of AJCC
* One primary tumor lesion amendable for intratumoral injection
* Ineligible to receive platinum-based chemotherapy with radiation (at least one of the following):

1. Estimated creatinine clearance >= 30 and less than (<) 50 milliliters/minute (mL/min) (per Cockcroft-Gault equation), Grade >= 2 hearing loss or tinnitus, Grade >= 2 peripheral neuropathy, Eastern Cooperative Oncology Group (ECOG) Performance Status 2 or New York Heart Association Class 3
2. Age 70-74 years old with Geriatric 8 (G8) score less than or equal to (<=) 14
3. Age >= 75 years old


Exclusion Criteria:

* Carcinoma of the nasopharynx, paranasal sinus(es), salivary gland, thyroid gland, or unknown primary
* Non-squamous cell histology
* Clinical stage T1-2 N0, T2 N1, or M1 disease according to the 8th edition of AJCC
* Loco-regionally recurrent head & neck cancer that has been previously treated with surgery, radiation therapy, and/or chemotherapy
* Prior or concurrent primary malignancy (including second synchronous head & neck cancer) within the last 2 years of informed consent and whose natural history has the potential to interfere with the safety and efficacy assessment of the investigational agent
* Ongoing or active infection requiring treatment with antimicrobial therapy within 2 weeks of randomization


Inclusion Criteria:

* Age greater than or equal to (>=) 60 years old
* Squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or supraglottic larynx and a candidate for definitive radiation therapy with or without cetuximab
* Clinical stage T3-4 NX or T2 N2-3 dis

More...

DETAILS

LOCATIONS

Locations in:
United States, Austria, Belgium, Brazil, Bulgaria, China, Czechia, France, Georgia, Germany, Greece, Hungary, India, Israel, Japan, South Korea, Philippines, Portugal, Romania, Spain, Taiwan, United Kingdom, Croatia, Finland, Serbia
Country (25) City or Province (159) Status
United States Laguna Hills Memorial Radiation Oncology Medical Group Laguna Hills
RECRUITING
United States Newport Beach Hoag Memorial Hospital
RECRUITING
United States San Francisco University of California San Francisco
RECRUITING
United States Tampa Moffitt Cancer Center
RECRUITING
United States Santa Fe Christus St. Vincent Regional Cancer Center
RECRUITING
United States Staten Island Richmond University Medical Center
RECRUITING
United States Chapel Hill University of North Carolina at Chapel Hill
RECRUITING
United States Oklahoma City Stephenson Cancer Center
RECRUITING
Austria Graz Medizinische Universität Graz
RECRUITING
Austria Linz Ordensklinikum Linz GmbH Barmherzige Schwestern
RECRUITING
Austria Wien Medizinische Universitaet Wien
RECRUITING
Belgium Brussels Cliniques Universitaires Saint Luc
RECRUITING
Belgium Gilly Grand Hôpital de Charleroi - Site Saint-Joseph
RECRUITING
Belgium Leuven Universitair Ziekenhuis Leuven
RECRUITING
Brazil Barretos Fundacao Pio Xii - Hospital De Cancer De Barretos
RECRUITING
Brazil Belo Horizonte Nucleo de Ensino e Pesquisa do Instituto Mario Penna
RECRUITING
Brazil Fortaleza Centro Regional Integrado de Oncologia CRIO
RECRUITING
Brazil Jau Hospital Amaral Carvalho
RECRUITING
Brazil Porto Alegre Hospital Sao Lucas da PUCRS
RECRUITING
Brazil Porto Alegre Hospital Nossa Senhora da Conceicao
RECRUITING
Brazil Rio De Janeiro Grupo Oncoclinicas - Botafogo
RECRUITING
Brazil Sao Paulo Hospital Sirio Libanes Sao Paulo
RECRUITING
Brazil Sao Paulo Irmandade da Santa Casa de Misericordia de Porto Alegre
RECRUITING
Brazil São José do Rio Preto Hospital de Base de Sao Jose do Rio Preto
RECRUITING
Bulgaria Panagyurishte MHAT Uni Hospital
RECRUITING
China Bengbu The Affiliated Hospital of Bengbu Medical College
RECRUITING
China Changsha Xiangya Hospital Central South University
COMPLETED
China ChangSha Hunan Cancer hospital
RECRUITING
China Chengdu Sichuan Cancer Hospital
RECRUITING
China Dongguan Dongguan People s Hospital
RECRUITING
China Fu Zhou Shi Fujian Medical University Union Hospital
RECRUITING
China Fuzhou The First Affiliated Hospital of Fujian Medical University
RECRUITING
China Fuzhou Fujian Medical University Fujian Provincial Cancer Hospital
RECRUITING
China Guangzhou The First Affiliated Hospital of Guangdong Pharmaceutical University
RECRUITING
China Guangzhou Guangzhou Medical University Affiliated Oncology Hospital
RECRUITING
China Guangzhou Guangzhou First Municipal People's Hospital
RECRUITING
China Jinan Qilu Hospital of Shandong University
RECRUITING
China Jinan Shandong Cancer Hospital
RECRUITING
China Linyi Linyi Cancer Hospital
RECRUITING
China Liuzhou Liuzhou people's Hospital
RECRUITING
China Nanchang Jiangxi Cancer Hospital
COMPLETED
China Nanjing Jiangsu Cancer Hospital
RECRUITING
China Nanjing Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
RECRUITING
China Nanning Wuming Hospital of Guangxi Medical University
RECRUITING
China Nanning The Cancer Hospital Affiliated to Guangxi Medical University
RECRUITING
China Qingdao The Affiliated Hospital of Medical College Qingdao University
RECRUITING
China Shanghai Fudan University Shanghai Cancer Center
RECRUITING
China Shen Zhen Shi Peking University Shenzhen Hospital
RECRUITING
China Shenyang Liaoning Cancer Hospital and Institute
RECRUITING
China Shijiazhuang The Fourth Hospital of Hebei Medical University
RECRUITING
China Suzhou Second Affiliated Hospital, SooChow University
RECRUITING
China Taiyuan Shanxi Provincial Cancer hospital
RECRUITING
China Tianjin Tianjin Medical University Cancer Institute and Hospital
RECRUITING
China Wuhan Union Hospital Tongji Medical College of Huazhong University of Science and Technology
RECRUITING
China Wuhan Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology
RECRUITING
China Wuhan Hubei Cancer Hospital
RECRUITING
China Xiamen The first affiliated hospital of xiamen university
RECRUITING
China Xuzhou The Affiliated Hospital of Xuzhou Medical University
RECRUITING
China Zhengzhou Henan Cancer Hospital
COMPLETED
China Zhuhai The Fifth Affiliated Hospital Sun Yat Sen University
RECRUITING
Czechia Olomouc Fakultni nemocnice Olomouc
RECRUITING
Czechia Praha 8 Nemocnice Bulovka
RECRUITING
France Amiens CHU Amiens Picardie
RECRUITING
France Brest CHU Brest
RECRUITING
France Caen Cedex 05 Centre Francois Baclesse
RECRUITING
France Lille Cedex Centre de Lutte contre le Cancer Centre Oscar Lambret
SUSPENDED
France Lyon Centre Leon Berard
RECRUITING
France Marseille Hopital de la Timone
RECRUITING
France Neuilly Sur Seine Clinique Ambroise Pare
RECRUITING
France PARIS Cedex 5 Institut Curie
RECRUITING
France Paris Hopital Europeen Georges Pompidou
SUSPENDED
France Paris Hopital Tenon
RECRUITING
France Pessac Hopital Haut Leveque
RECRUITING
France Rennes Hopital Pontchaillou
RECRUITING
France Rouen Cedex 1 CLCC - Centre Henri Becquerel
RECRUITING
France Saint Etienne Cedex 2 CHU Saint Etienne
RECRUITING
France Valenciennes cedex Centre Hospitalier de Valenciennes Hopital Jean Bernard
RECRUITING
France Vandoeuvre les Nancy Institut de Cancerologie de Lorraine
RECRUITING
France Villejuif Cedex Gustave Roussy
RECRUITING
Georgia Batumi High Technology Hospital MedCenter Ltd Batumi
RECRUITING
Georgia Kutaisi JSC Vian Kutaisi Referral Hospital
RECRUITING
Georgia Tbilisi Todua Clinic
SUSPENDED
Georgia Tbilisi Ltd Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic
RECRUITING
Germany Giessen Universitaetsklinikum Giessen und Marburg GmbH
RECRUITING
Germany Jena Universitatsklinikum Jena
RECRUITING
Germany München Klinikum rechts der Isar an der Technischen Universitat Munchen
RECRUITING
Germany Rostock Universitaetsmedizin Rostock
RECRUITING
Greece Athens General Hospital of Athens Attikon
RECRUITING
Greece Larissa University Hospital Of Larissa
RECRUITING
Greece Thessaloniki Interbalkan Medical Center of Thessaloniki
RECRUITING
Hungary Budapest Eszak Pesti Centrumkorhaz Honvedkorhaz
RECRUITING
Hungary Budapest Orszagos Onkologiai Intezet
RECRUITING
Hungary Szeged Szent Gyorgyi Albert Klinikai Kozpont Onkoterapias Klinika
RECRUITING
India Bangalore M S Ramaiah Memorial Hospital
RECRUITING
India Chennai Apollo Speciality Hospital, Chennai
RECRUITING
India Madhurai Meenakshi Mission Hospital and Research Center
COMPLETED
India Mumbai Tata Memorial Hospital
RECRUITING
India Nashik HealthCare Global HCG Manavata Cancer Centre
RECRUITING
India Pune Grant Medical foundation Ruby Hall Clinic
RECRUITING
Israel Ashdod Samson Assuta Ashdod University Hospital
RECRUITING
Israel Haifa Rambam Health Care Campus
RECRUITING
Israel Jerusalem Hadassah Medical Center
SUSPENDED
Israel Tel Aviv Tel Aviv Sourasky Medical Center
RECRUITING
Japan Bunkyo Tokyo Medical and Dental University Hospital
RECRUITING
Japan Hiroshima shi Hiroshima University Hospital
RECRUITING
Japan Kashiwa National Cancer Center Hospital East
RECRUITING
Japan Nagoya Aichi Cancer Center
RECRUITING
Japan Osaka Sayama shi Kindai University Hospital
RECRUITING
Japan Osaka Osaka International Cancer Institute
RECRUITING
Japan Sendai-Shi Tohoku University Hospital
RECRUITING
Japan Shimotsuke Jichi Medical University Hospital
RECRUITING
Japan Shinjuku Tokyo Medical University Hospital
RECRUITING
Japan Sunto Gun Shizuoka Cancer Center
RECRUITING
South Korea Seoul Korea University Anam Hospital
RECRUITING
South Korea Seoul Severance Hospital
RECRUITING
South Korea Seoul The Catholic University of Korea Seoul St Mary s Hospital
RECRUITING
South Korea Seoul Asan Medical Center (AMC)
RECRUITING
South Korea Suwon si The Catholic university of Korea, St. Vincent's Hospital
RECRUITING
South Korea Suwon si Ajou University Hospital
COMPLETED
Philippines Las Pinas University of Perpetual Help Dalta Medical Center, Inc
RECRUITING
Philippines Manila Manila Doctors Hospital
RECRUITING
Philippines Pasig The Medical City
RECRUITING
Philippines Quezon City St. Luke's Medical Center
RECRUITING
Portugal Braga Uls Braga - Hosp. Braga
COMPLETED
Portugal Lisboa Hosp. Cuf Descobertas
RECRUITING
Portugal Vila Nova de Gaia Uls Gaia Espinho
RECRUITING
Romania Bucuresti Institutul Oncologic Prof Dr Al Trestioreanu Bucuresti
RECRUITING
Spain Barakaldo Hosp. Univ. de Cruces
RECRUITING
Spain Barcelona Hosp Clinic de Barcelona
RECRUITING
Spain Barcelona Hosp Univ Vall D Hebron
RECRUITING
Spain L Hospitalet De Llobregat Instituto Catalan Deoncologia Hospital Duran I Reynals
RECRUITING
Spain Lugo Hosp. Univ. Lucus Augusti
RECRUITING
Spain Madrid Hosp Univ Fund Jimenez Diaz
RECRUITING
Spain Madrid Hosp. Univ. 12 de Octubre
RECRUITING
Spain Madrid Hosp Univ Hm Sanchinarro
RECRUITING
Spain Málaga Hosp Regional Univ de Malaga
RECRUITING
Spain Santander Hosp. Univ. Marques de Valdecilla
RECRUITING
Spain Sevilla Hosp. Virgen Del Rocio
RECRUITING
Spain Valencia Inst. Valenciano de Oncologia
RECRUITING
Taiwan Bei Qu National Cheng Kung University Hospital
RECRUITING
Taiwan Changhua Changhua Christian Hospital
RECRUITING
Taiwan Keelung Chang-Gung Memorial Hospital-Keelung
RECRUITING
Taiwan Taichung Taichung Veterans General Hospital
RECRUITING
Taiwan Taipei National Taiwan University Hospital
RECRUITING
United Kingdom Glasgow NHS Greater Glasgow and Clyde
RECRUITING
United Kingdom Guildford The Royal Surrey County Hospital NHS Foundation Trust
RECRUITING
United Kingdom Newcastle upon Tyne Newcastle upon Tyne Hospitals NHS Foundation Trust
RECRUITING
United States New York Herbert Irving Comprehensive Cancer Center Columbia University Medical Center
COMPLETED
Spain Valencia Hosp. Gral. Univ. Valencia
RECRUITING
United States Los Angeles UCLA Hematology Oncology
RECRUITING
Bulgaria Sofia Specialized Hospital for Active Treatment in Oncology
COMPLETED
Croatia Zagreb Klinicki bolnicki centar Zagreb
COMPLETED
Finland Tampere Tampereen Yliopistollinen Sairaala
COMPLETED
Serbia Belgrade Institute of Oncology and Radiology of Serbia
COMPLETED
Serbia Belgrade Vojnomedicinska Akademija
COMPLETED
Serbia Kragujevac University Clinical Center Kragujevac
COMPLETED
Serbia Sremska Kamenica Institute of Oncology of Vojvodina
COMPLETED
Spain Las Palmas de Gran Canaria Hospitales Universitarios San Roque En Las Palmas de Gran Canaria Centro Oncologico Integral Canario
TERMINATED
Spain Pamplona Hosp. de Navarra
TERMINATED
Show More
Geo Locations

33.61252, -117.71283

33.61891, -117.92895

37.77493, -122.41942

27.94752, -82.45843

35.68698, -105.9378

40.56233, -74.13986

35.9132, -79.05584

35.46756, -97.51643

47.06667, 15.45

48.30639, 14.28611

48.20849, 16.37208

50.85045, 4.34878

50.42449, 4.4789

50.87959, 4.70093

-20.55722, -48.56778

-19.92083, -43.93778

-3.71722, -38.54306

-22.29639, -48.55778

-30.03306, -51.23

-30.03306, -51.23

-22.90278, -43.2075

-23.5475, -46.63611

-23.5475, -46.63611

-20.81972, -49.37944

42.4952, 24.19017

32.94083, 117.36083

28.19874, 112.97087

28.19874, 112.97087

30.66667, 104.06667

23.01797, 113.74866

26.0855999, 119.307

26.06139, 119.30611

26.06139, 119.30611

23.11667, 113.25

23.11667, 113.25

23.11667, 113.25

36.66833, 116.99722

36.66833, 116.99722

35.06306, 118.34278

24.3239844, 109.4318605

28.68396, 115.85306

32.06167, 118.77778

32.06167, 118.77778

22.81667, 108.31667

22.81667, 108.31667

36.06488, 120.38042

31.22222, 121.45806

22.5615299, 114.05462

41.79222, 123.43278

38.04139, 114.47861

31.30408, 120.59538

37.86944, 112.56028

39.14222, 117.17667

30.58333, 114.26667

30.58333, 114.26667

30.58333, 114.26667

24.47979, 118.08187

34.18045, 117.15707

34.75778, 113.64861

22.27694, 113.56778

49.59552, 17.25175

50.08804, 14.42076

49.9, 2.3

48.3903, -4.48628

49.18585, -0.35912

50.63297, 3.05858

45.74848, 4.84669

43.29551, 5.38958

48.8846, 2.26965

48.85341, 2.3488

48.85341, 2.3488

48.85341, 2.3488

44.81011, -0.64129

48.11198, -1.67429

49.44313, 1.09932

45.43389, 4.39

50.35, 3.53333

48.65, 6.18333

48.7939, 2.35992

41.64228, 41.63392

42.26791, 42.69459

41.69411, 44.83368

41.69411, 44.83368

50.58727, 8.67554

50.92878, 11.5899

48.13743, 11.57549

54.0887, 12.14049

37.97945, 23.71622

39.63689, 22.41761

40.64361, 22.93086

47.49801, 19.03991

47.49801, 19.03991

46.253, 20.14824

12.97194, 77.59369

13.08784, 80.27847

9.9642971, 78.1735438

19.07283, 72.88261

19.99727, 73.79096

18.51957, 73.85535

31.79211, 34.64967

32.81841, 34.9885

31.76904, 35.21633

32.08088, 34.78057

35.37517, 139.92991

34.4, 132.45

35.86224, 139.97732

35.18147, 136.90641

34.69374, 135.50218

34.69374, 135.50218

38.26667, 140.86667

36.41323, 139.86622

35.2946, 139.57059

35.1565356, 138.8845111

37.566, 126.9784

37.566, 126.9784

37.566, 126.9784

37.566, 126.9784

37.29111, 127.00889

37.29111, 127.00889

14.4561507, 120.9945653

14.6042, 120.9822

14.58691, 121.0614

14.6488, 121.0509

41.55032, -8.42005

38.71667, -9.13333

41.13363, -8.61742

44.42802, 26.09665

43.29639, -2.98813

41.38879, 2.15899

41.38879, 2.15899

41.3491194, 2.1229311

43.00992, -7.55602

40.4165, -3.70256

40.4165, -3.70256

40.4165, -3.70256

36.72016, -4.42034

43.46472, -3.80444

37.38283, -5.97317

39.46975, -0.37739

23.008515, 120.2079953

24.07327, 120.56276

25.12825, 121.7419

24.1469, 120.6839

25.04776, 121.53185

55.86515, -4.25763

51.23536, -0.57427

54.97328, -1.61396

40.71427, -74.00597

39.46975, -0.37739

34.05223, -118.24368

42.69751, 23.32415

45.81444, 15.97798

61.49911, 23.78712

44.80401, 20.46513

44.80401, 20.46513

44.01667, 20.91667

45.22158, 19.84367

28.09973, -15.41343

42.81687, -1.64323

x
50

Indicates 50+ sites in this region: click to zoom in.

10

Indicates 10+ sites in this region: click to zoom in.

5

Indicates < 10 sites in this region: click to zoom in.

Corresponds to individual site.

Interested in participating?

×

Confirm


If you are interested in this clinical trial, we will use your email address to respond to your questions and fulfill your requests as necessary for our legitimate interest and possibly to comply with our legal obligations relating to pharmacovigilance. Please read our Privacy Policy.

Footer

  • PRIVACY POLICY
  • LEGAL NOTICE
  • COOKIE POLICY
  • COOKIE SETTINGS
  • CAREERS
  • NEWS CENTER
  • DO NOT SELL MY PERSONAL INFORMATION

Footer Social

Find Janssen Global on:

twitter youtube linkedin

Janssen Global Policy text

©Johnson & Johnson Innovative Medicine. All Rights Reserved. This website is hosted and operated by Johnson & Johnson Innovative Medicine, which is solely responsible for its content. This website is intended for a global audience.